Introducing RapidCert™ Biological Indicator (BI) Sterility TestingNelson Labs’ patent-pending solution for quicker sterility confirmation. Learn More
Header Artwork
Header Artwork

ON-DEMAND WEBINAR

Virucidal-Efficacy Testing for Submission to Regulatory Agencies

Published Date: June 22, 2022

Virucidal-efficacy testing is a type of testing that is used to determine the effect of disinfectants or antiseptic products on viruses. Antiviral testing describes methodologies applied to study antiviral drugs. Virucidal products are aimed at reducing or eliminating viruses from inanimate surfaces (disinfectants, antimicrobial coated surfaces) and human skin (antiseptics). Antiviral drugs target viral diseases of humans or animals.

This webinar provides a general overview of methodologies for virucidal-efficacy testing that are recognized by different regulatory agencies and used for virucidal label claims. The webinar will include details on critical testing requirements and acceptance criteria of current standardized and modified methodologies applied by the Virology Laboratory at Nelson Laboratories.

Learn more about the presenter below.

15403

Volha Teagle

Department Scientist, Virology

Dr. Teagle worked for more than 15 years as a Principal Scientist and the Virology Laboratory Manager at Nelson Labs. Dr. Teagle gained post-doctoral experience working with Varicella Zoster virus at the CDC in Atlanta. She leads Viral Clearance and other studies and provides scientific support to the study directors in the Virology Lab at Nelson Labs.

Complete the form below to access the webinar.